172@29@16@54!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=0&is_responsive=1&sec=PNC_FINANCIAL&priceinter=1&frommc=1!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_header.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
you are here:

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals

BSE Live

Oct 22, 16:00
782.45 -22.85 (-2.84%)
Volume
AVERAGE VOLUME
5-Day
68,612
10-Day
92,633
30-Day
150,275
346,002
  • Prev. Close

    805.30

  • Open Price

    809.80

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 22, 15:59
782.20 -24.00 (-2.98%)
Volume
AVERAGE VOLUME
5-Day
2,323,476
10-Day
2,690,163
30-Day
3,859,677
12,465,607
  • Prev. Close

    806.20

  • Open Price

    807.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    782.20 (6709)

Financials

2019 2018 2017 2016 2015
Profit & Loss account of Aurobindo Pharma (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 12,934.53 11,938.70 10,041.96 9,539.36 9,078.96  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 33.25 174.16 156.58  
Revenue From Operations [Net] 12,934.53 11,938.70 10,008.71 9,365.20 8,922.38  
Total Operating Revenues 13,266.48 12,257.89 10,269.90 9,607.05 9,166.18  
Other Income 403.37 199.22 80.65 135.95 188.36  
Total Revenue 13,669.85 12,457.11 10,350.55 9,743.00 9,354.54  
EXPENSES  
Cost Of Materials Consumed 6,747.55 6,455.30 4,893.27 4,604.19 4,425.80  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -229.53 -289.80 -337.20 31.32 -141.59  
Employee Benefit Expenses 1,561.47 1,362.77 1,131.64 927.30 807.05  
Finance Costs 240.94 230.86 52.89 45.16 229.31  
Depreciation And Amortisation Expenses 470.48 413.03 354.83 286.17 263.00  
Other Expenses 2,495.73 2,306.08 1,908.46 1,659.08 1,616.82  
Total Expenses 11,292.15 10,492.49 8,007.61 7,564.43 7,206.70  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 2,377.70 1,964.62 2,342.94 2,178.57 2,147.84  
Exceptional Items 0.00 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 2,377.70 1,964.62 2,342.94 2,178.57 2,147.84  
Tax Expenses-Continued Operations  
Current Tax 505.86 426.61 505.34 462.06 518.23  
Less: MAT Credit Entitlement 0.00 48.05 43.32 64.28 0.00  
Deferred Tax -0.90 56.33 68.15 74.03 2.91  
Tax For Earlier Years 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 504.96 434.89 530.17 471.81 521.14  
Profit/Loss After Tax And Before ExtraOrdinary Items 1,872.74 1,529.73 1,812.77 1,706.76 1,626.70  
Profit/Loss From Continuing Operations 1,872.74 1,529.73 1,812.77 1,706.76 1,626.70  
Profit/Loss For The Period 1,872.74 1,529.73 1,812.77 1,706.76 1,626.70  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 31.96 26.11 30.94 29.16 27.85  
Diluted EPS (Rs.) 31.96 26.11 30.94 29.16 27.85  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 15.15  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 122.76  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 175.78 146.48 219.71 114.11 134.37  
Tax On Dividend 9.66 13.86 44.73 23.23 27.36  
Equity Dividend Rate (%) 300.00 250.00 250.00 250.00 250.00  
Source : Dion Global Solutions Limited